140 related articles for article (PubMed ID: 34895811)
1. The two sides of creatine in cancer.
Zhang L; Bu P
Trends Cell Biol; 2022 May; 32(5):380-390. PubMed ID: 34895811
[TBL] [Abstract][Full Text] [Related]
2. Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression.
Patel R; Ford CA; Rodgers L; Rushworth LK; Fleming J; Mui E; Zhang T; Watson D; Lynch V; Mackay G; Sumpton D; Sansom OJ; Vande Voorde J; Leung HY
Cancer Res; 2022 Jul; 82(14):2565-2575. PubMed ID: 35675421
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine).
Griffiths GR; Walker JB
J Biol Chem; 1976 Apr; 251(7):2049-54. PubMed ID: 1270421
[TBL] [Abstract][Full Text] [Related]
4. Creatine promotes cancer metastasis through activation of Smad2/3.
Zhang L; Zhu Z; Yan H; Wang W; Wu Z; Zhang F; Zhang Q; Shi G; Du J; Cai H; Zhang X; Hsu D; Gao P; Piao HL; Chen G; Bu P
Cell Metab; 2021 Jun; 33(6):1111-1123.e4. PubMed ID: 33811821
[TBL] [Abstract][Full Text] [Related]
5. HIF-Dependent CKB Expression Promotes Breast Cancer Metastasis, Whereas Cyclocreatine Therapy Impairs Cellular Invasion and Improves Chemotherapy Efficacy.
Krutilina RI; Playa H; Brooks DL; Schwab LP; Parke DN; Oluwalana D; Layman DR; Fan M; Johnson DL; Yue J; Smallwood H; Seagroves TN
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008190
[TBL] [Abstract][Full Text] [Related]
6. Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma.
Patra S; Bera S; SinhaRoy S; Ghoshal S; Ray S; Basu A; Schlattner U; Wallimann T; Ray M
FEBS J; 2008 Jun; 275(12):3236-47. PubMed ID: 18485002
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine).
Roberts JJ; Walker JB
Arch Biochem Biophys; 1983 Feb; 220(2):563-71. PubMed ID: 6824340
[TBL] [Abstract][Full Text] [Related]
8. Enhanced ability of skeletal muscle containing cyclocreatine phosphate to sustain ATP levels during ischemia following beta-adrenergic stimulation.
Turner DM; Walker JB
J Biol Chem; 1987 May; 262(14):6605-9. PubMed ID: 3571272
[TBL] [Abstract][Full Text] [Related]
9. Creatine supplementation: exploring the role of the creatine kinase/phosphocreatine system in human muscle.
Hespel P; Eijnde BO; Derave W; Richter EA
Can J Appl Physiol; 2001; 26 Suppl():S79-102. PubMed ID: 11897886
[TBL] [Abstract][Full Text] [Related]
10. Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
Bergnes G; Yuan W; Khandekar VS; O'Keefe MM; Martin KJ; Teicher BA; Kaddurah-Daouk R
Oncol Res; 1996; 8(3):121-30. PubMed ID: 8823808
[TBL] [Abstract][Full Text] [Related]
11. Changes of tissue creatine concentrations upon oral supplementation of creatine-monohydrate in various animal species.
Ipsiroglu OS; Stromberger C; Ilas J; Höger H; Mühl A; Stöckler-Ipsiroglu S
Life Sci; 2001 Aug; 69(15):1805-15. PubMed ID: 11665842
[TBL] [Abstract][Full Text] [Related]
12. Normal cardiac function in mice with supraphysiological cardiac creatine levels.
Santacruz L; Hernandez A; Nienaber J; Mishra R; Pinilla M; Burchette J; Mao L; Rockman HA; Jacobs DO
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H373-81. PubMed ID: 24271489
[TBL] [Abstract][Full Text] [Related]
13. Mathematical model of compartmentalized energy transfer: its use for analysis and interpretation of 31P-NMR studies of isolated heart of creatine kinase deficient mice.
Aliev MK; van Dorsten FA; Nederhoff MG; van Echteld CJ; Veksler V; Nicolay K; Saks VA
Mol Cell Biochem; 1998 Jul; 184(1-2):209-29. PubMed ID: 9746323
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices.
Enrico A; Patrizia G; Luisa P; Alessandro P; Gianluigi L; Carlo G; Maurizio B
J Integr Neurosci; 2013 Jun; 12(2):285-97. PubMed ID: 23869866
[TBL] [Abstract][Full Text] [Related]
15. Differential response of muscle phosphocreatine to creatine supplementation in young and old subjects.
Rawson ES; Clarkson PM; Price TB; Miles MP
Acta Physiol Scand; 2002 Jan; 174(1):57-65. PubMed ID: 11851597
[TBL] [Abstract][Full Text] [Related]
16. Utilization of cyclocreatine phosphate, and analogue of creatine phosphate, by mouse brain during ischemia and its sparing action on brain energy reserves.
Woznicki DT; Walker JB
J Neurochem; 1980 May; 34(5):1247-53. PubMed ID: 7373304
[No Abstract] [Full Text] [Related]
17. Formation and utilization of novel high energy phosphate reservoirs in Ehrlich ascites tumor cells. Cyclocreatine-3-P and creatine-P.
Annesley TM; Walker JB
J Biol Chem; 1978 Nov; 253(22):8120-5. PubMed ID: 568626
[No Abstract] [Full Text] [Related]
18. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
Matthews RT; Yang L; Jenkins BG; Ferrante RJ; Rosen BR; Kaddurah-Daouk R; Beal MF
J Neurosci; 1998 Jan; 18(1):156-63. PubMed ID: 9412496
[TBL] [Abstract][Full Text] [Related]
19. The beneficial effect of phosphocreatine accumulation in the creatine kinase transgenic mouse liver in endotoxin-induced hepatic cell death.
Kanazawa A; Tanaka A; Iwata S; Satoh S; Hatano E; Shinohara H; Kitai T; Tsunekawa S; Ikai I; Yamamoto M; Takahashi R; Chance B; Yamaoka Y
J Surg Res; 1998 Dec; 80(2):229-35. PubMed ID: 9878318
[TBL] [Abstract][Full Text] [Related]
20. Effects of repeated creatine supplementation on muscle, plasma, and urine creatine levels.
Rawson ES; Persky AM; Price TB; Clarkson PM
J Strength Cond Res; 2004 Feb; 18(1):162-7. PubMed ID: 14971966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
